RICHMOND, Calif.--Acacia Biosciences here and Novartis Crop Protection announced the signing of a profiling agreement to utilize Acacia's patented Genome Reporter Matrix to aid in the selection and optimization of lead compounds for crop-protection products. Under the agreement, Acacia will provide chemical and biological profiles on a class of Novartis's compounds for an undisclosed fee.
The patented technology incorporates a microarray that measures changes in gene expression with a comprehensive database of expression profiles and a set of software tools that facilitate the comparison of profiles and the discovery of new genes and targets. Acacia said the first generation of this technology is based on the fully sequenced yeast genome.